PMPY

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024

Retrieved on: 
Wednesday, March 27, 2024
Growth, Prescription, Earnout, Depreciation, Eastern Time Zone, PMPY, FFS, Pharmaceutical industry

Consolidated revenue for Q4 2023 was $86 million, an increase of 20.1% compared to Q4 2022, and a 4.6% increase compared to Q3 2023.

Key Points: 
  • Consolidated revenue for Q4 2023 was $86 million, an increase of 20.1% compared to Q4 2022, and a 4.6% increase compared to Q3 2023.
  • Gross profit in Q4 2023 was $14 million, a decrease of 8.0% compared to Q4 2022.
  • Gross profit is calculated by subtracting direct costs of patient services, dispensary, and clinical trials and other from consolidated revenues.
  • TOI will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. (Eastern Time) to discuss fourth quarter and full year results and management’s outlook for future financial and operational performance.

Prometheum Prodigy (PMPY) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Sunday, January 21, 2024
Artificial intelligence, Decentralized finance, AI, PMPY, Prometheum, Blockchain, Cryptocurrency

LBank Exchange is thrilled to announce the listing of Prometheum Prodigy (PMPY), a pioneering Ai Layer 2 blockchain platform, ingeniously crafted atop the Ethereum network.

Key Points: 
  • LBank Exchange is thrilled to announce the listing of Prometheum Prodigy (PMPY), a pioneering Ai Layer 2 blockchain platform, ingeniously crafted atop the Ethereum network.
  • By integrating state-of-the-art cybersecurity and artificial intelligence (AI) technologies, Prometheum Prodigy sets out to revolutionize the blockchain landscape.
  • By employing advanced Ai Layer 2 scaling techniques, Prometheum Prodigy strives to reduce transaction costs while simultaneously increasing the throughput of the Ethereum network.
  • Moreover, the Prodigy Robotic Sniper represents a cutting-edge solution in DeFi crypto trading, powered by legendary algorithmic trading functionalities and advanced AI.

Salesforce CMO (Former), Dr. Geeta Nayyar, MD Joins MDI Health

Retrieved on: 
Thursday, December 14, 2023
Software, Pharmaceutical, General Health, Health, Artificial Intelligence, Health Technology, Technology, Other Technology, Organization, Patient safety, PMPY, MDI, American Telemedicine Association, Automation, CMO, AI, Knowledge, AT&T, Medical device, Salesforce

MDI Health , an AI-powered platform that optimizes personalized medication treatment at scale, announced that the former Chief Medical Officer of Salesforce, Dr. Geeta Nayyar will join MDI Health’s advisory board.

Key Points: 
  • MDI Health , an AI-powered platform that optimizes personalized medication treatment at scale, announced that the former Chief Medical Officer of Salesforce, Dr. Geeta Nayyar will join MDI Health’s advisory board.
  • “MDI Health is using innovative technology to solve one of the most pressing issues in healthcare, problems that stems from medication treatment.
  • Avishai Ben-Tovim, CEO and Co-founder of MDI Health, commented: “We are thrilled to have a healthcare technology leader such as Dr. Nayyar join our team.
  • I am confident that Dr. Nayyar’s guidance will be invaluable as we revolutionize the way medication treatment is optimized with technology.”

MSSP ACOs Leveraging Lightbeam Achieved a Remarkable $509M in Generated Savings in PY 2022

Retrieved on: 
Wednesday, September 20, 2023
Public Policy, Government, Software, Health, Healthcare Reform, Health Technology, Technology, Other Technology, Other Health, ACO, CMS, Booth, Health equity, Light beam, Acos, Organization, PMPY, Population health, Careers advisory service, RPM, HCC, Pharmaceutical industry, MSSP

Since 2014, MSSP ACOs leveraging Lightbeam’s technology and solutions have generated more than $2.5B in total savings.

Key Points: 
  • Since 2014, MSSP ACOs leveraging Lightbeam’s technology and solutions have generated more than $2.5B in total savings.
  • Lightbeam clients actively engaged with Advisory Services generated an average PMPY savings of $513, which is 30% higher than ACOs not using Lightbeam.
  • MSSP ACOs leveraging Lightbeam’s Deviceless RPM achieved $348 per beneficiary in earned savings, higher than the average for all ACOs at $242 in earned savings per beneficiary.
  • Since 2014, MSSP ACOs leveraging Lightbeam’s technology and solutions have generated more than $2.5B in total savings.

Study Shows Employers Save 25% Through Onsite and Nearsite Wellness Centers

Retrieved on: 
Tuesday, September 19, 2023
Clutch (eggs), Milliman, Health, ROI, PMPY, Pharmaceutical industry, Nursing, Health insurance

BRENTWOOD, Tenn., Sept. 19, 2023 /PRNewswire/ -- Onsite and nearsite wellness centers save employers an average of 25% on their employees' and dependents' total cost of care, a large, representative, claims-based analysis of more than 148,000 individuals shows.

Key Points: 
  • BRENTWOOD, Tenn., Sept. 19, 2023 /PRNewswire/ -- Onsite and nearsite wellness centers save employers an average of 25% on their employees' and dependents' total cost of care, a large, representative, claims-based analysis of more than 148,000 individuals shows.
  • It analyzed data across 19 employers in nine industries, making it one of the largest studies ever conducted in the onsite and nearsite health care industry.
  • Wellness centers save employers an average of 25% on total cost of care, a claims-based analysis of 148,000 lives shows.
  • The study showed that onsite and nearsite health led to:
    Clark credits the accessibility of high-quality health care through onsite and nearsite wellness centers as a driving force for reduced employer health care spend.

Benefits of Integrating Medical and Pharmacy Coverage Include Greater Savings, Fewer Trips to the Hospital and ER

Retrieved on: 
Wednesday, July 19, 2023
COPD, HTN, Asthma, Depression, RA, DM, Hospital, CAD, Research, Pharmacy, Multiple sclerosis, MS, Hypertension, Chronic obstructive pulmonary disease, Hyperlipidemia, Blue Shield, PMPY, Data, Type 2 diabetes, Lipid, PBM, ASO, Blue Cross, Coronary artery disease, Health, Therapy, CHF, Rheumatoid arthritis, Health insurance, Pharmaceutical industry, Medicaid, Medicare

EAGAN, Minn., July 19, 2023 /PRNewswire/ -- According to a new two-year analysis released by Blue Cross and Blue Shield of Minnesota (Blue Cross), employer-based health plans with fully integrated medical and pharmacy benefits can generate an average of more than $400 in annual savings on a per-member basis when compared to non-integrated options.

Key Points: 
  • In addition to evaluating medical costs, the Blue Cross analysis compared the rate of hospitalizations and emergency room visits between the two member groups.
  • "The report also underscores why it makes such good sense for employers to have one point of contact when managing medical and pharmacy needs."
  • Members with a specialty drug condition of either rheumatoid arthritis (RA) or multiple sclerosis (MS) were assessed as a separate group.
  • An electronic copy of the full report is available upon request from the media contact at Blue Cross and Blue Shield of Minnesota.

Out of Control: U.S. Employers Spend $245B a Year on Diabetes as Diagnosis Rates Rise, New Nomi Health Data Shows

Retrieved on: 
Tuesday, March 14, 2023
Medical Supplies, Hospitals, Diabetes, Health Insurance, Biotechnology, Managed Care, Health, Pharmaceutical, General Health, Spend, Disease, Artemis, Attention, Research, PMPY, Korea Disease Control and Prevention Agency, American Diabetes Association, COVID, Insulin, Prediabetes, Patient, Ketoacidosis, Kidney disease, Civica, Pharmacy, Pharmaceutical industry

Diabetes costs U.S. employers approximately $245 billion a year — more than double what the entire American automotive industry is worth, according to new data announced today by Nomi Health .

Key Points: 
  • Diabetes costs U.S. employers approximately $245 billion a year — more than double what the entire American automotive industry is worth, according to new data announced today by Nomi Health .
  • As part of the Nomi Health Trends in Spend Tracker — a series using claims analysis data to call attention and action to key shifts in healthcare costs — Nomi Health analyzed nearly half a million employer health insurance claims to reveal changes in employer spend on diabetes.
  • We must turn these spend insights into meaningful action,” Nomi Health Co-founder and CEO Mark Newman said.
  • Previous Nomi Health Trends in Spend Trackers explored pediatric mental health utilization and the costs of long COVID , which outpaced diabetes in 2022 employer health care costs.

Youth Mental Health Telehealth Costs Increase 20K% for Employers Across Utah, Nationwide Amid Double-digit Jumps in Diagnoses, Suicide Attempts

Retrieved on: 
Wednesday, January 4, 2023
Mental Health, Health, Telemedicine, Virtual Medicine, Other Health, Health Insurance, Managed Care, General Health, Spend, Artemis, Mental health, Anxiety, PTSD, National Alliance on Mental Illness, Utahn, Utah, Suicide, PMPY, Research, Depression, Adolescence, Workforce, Patient, Self-harm, Attention, Mental, Provo–Orem metropolitan area, Post-traumatic stress disorder, National Alliance, Diabetes, Diagnosis, COVID, Ogden–Clearfield metropolitan area, Pharmaceutical industry, Medicine, Mobile phone

Data from the analysis also indicates the youth suicide attempt rate soared 55% in the U.S. from 2019 to 2021.

Key Points: 
  • Data from the analysis also indicates the youth suicide attempt rate soared 55% in the U.S. from 2019 to 2021.
  • In Utah, 665 lives were lost to suicide and 141,000 adults had thoughts of suicide in the last year.
  • “With healthcare costs spiking and widening the gap between those who do and do not have access, mental health care cannot go unaddressed.
  • The nationwide 3-digit number for mental health crisis and suicide prevention services via phone, text and chat is 988.

20,000% Increase for Employers: Youth Mental Health Telehealth Costs Soar Amid Double-Digit Jumps in Diagnoses, Suicide Attempts

Retrieved on: 
Thursday, December 8, 2022
Mental Health, Hospitals, Telemedicine, Virtual Medicine, Health Insurance, Biotechnology, Managed Care, Health, Pharmaceutical, General Health, Spend, Artemis, Post-traumatic stress disorder, Suicide, Mental, Adolescence, Diagnosis, American Academy, Public health, Patient, COVID, Research, PTSD, City, Diabetes, Mental health, Attention, COVID-19, Self-harm, Health, PMPY, Workforce, Pediatrics (journal), Pharmacy, Depression, Anxiety, Pediatrics, Pharmaceutical industry, Mobile phone, Hospital, Medicine, Healthcare

Are we prepared to manage costs to take mental health utilization trends into account?

Key Points: 
  • Are we prepared to manage costs to take mental health utilization trends into account?
  • Nomi Healths Trends in Spend Tracker research also found:
    A mental health diagnosis makes a childs care costs skyrocket.
  • With healthcare costs spiking and widening the gap between those who do and do not have access, mental health care cannot go unaddressed.
  • The nationwide 3-digit number for mental health crisis and suicide prevention services via phone, text and chat is 988.

Over $2 Billion in Total MSSP Savings Generated by ACOs Leveraging Lightbeam’s Population Health Solutions & Services

Retrieved on: 
Tuesday, September 27, 2022
Technology, Hospitals, Other Technology, Software, Practice Management, Other Health, Managed Care, General Health, Health, Data Management, ACO, Table, Convention center, Light, PMPY, Accountable care organization, Twitter, Gaylord Texan Resort Hotel & Convention Center, MSSP, LinkedIn, Population, Acos, Light beam, Health equity, Program, Patient, REACH, CEO, Solution, British Pregnancy Advisory Service, AMGA, Health insurance, Pharmaceutical industry

Lightbeam Health Solutions , the leader in population health management solutions and services, today announced that Accountable Care Organizations (ACOs) leveraging Lightbeam technologies amassed a gross savings of $491 million for the Medicare Shared Savings Program (MSSP) in performance year (PY) 2021.

Key Points: 
  • Lightbeam Health Solutions , the leader in population health management solutions and services, today announced that Accountable Care Organizations (ACOs) leveraging Lightbeam technologies amassed a gross savings of $491 million for the Medicare Shared Savings Program (MSSP) in performance year (PY) 2021.
  • In PY 2021, ACOs leveraging Lightbeams Advisory Services generated an average of $10.6 million in savings and an average per-member-per-year (PMPY) savings of $425, which is 18% higher than ACOs not using Lightbeam.
  • Since 2014, ACOs in the MSSP program using Lightbeams solutions and services have generated billions in savings.
  • For more information about Lightbeams MSSP savings, visit Lightbeam Health Solutions at Table #2 at AMGA IQL22 from September 29 October 1, 2022.